NAFDAC blacklists Indian company over substandard drugs
The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted a pharmaceutical company for allegedly producing substandard and falsified medicines. The Director General (DG) of NAFDAC, Prof. Mojisola Christianah Adeyeye, on Sunday, said the agency blacklisted Mars Remedies PVT Limited, India, for manufacturing falsified Ciprofloxacin BP 500mg tablets (NAFDAC REG. NO C4-0498). […]
The National Agency for Food and Drug Administration and Control (NAFDAC)
The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted a pharmaceutical company for allegedly producing substandard and falsified medicines.
The Director General (DG) of NAFDAC, Prof. Mojisola Christianah Adeyeye, on Sunday, said the agency blacklisted Mars Remedies PVT Limited, India, for manufacturing falsified Ciprofloxacin BP 500mg tablets (NAFDAC REG. NO C4-0498).
The Indian company produced the tablets for Pinnacle Health Pharmaceutical Ltd located at 16/18, Nuru Oniwo Street, Surulere, Lagos, NAFDAC said.
As a measure to prevent future occurrence of falsified drugs, NAFDAC insisted that with immediate effect all products manufactured by the company, located in Gujarat, India, would not be allowed into Nigeria.
The NAFDAC DG warned all manufacturers and importers of medicines to adhere strictly to the conditions for which their products were registered by the agency or face a similar sanction.